Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study - Banerji, U; van Herpen, CML; Saura, C (The Lancet Oncology, 2019)
et al.